Status:
RECRUITING
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Lead Sponsor:
Sanoculis Ltd
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
40-85 years
Brief Summary
A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation o...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 1\. Subject who underwent MIMS® inferonasal procedure, and surgery was performed not earlier than 24 months from enrollment
Exclusion
Key Trial Info
Start Date :
November 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT06577857
Start Date
November 4 2022
End Date
June 30 2025
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S. Malayan Eye Center
Yerevan, Armenia